Lifesciences | North Carolina

Altis Biosystems Closed $3.1 Million Seed Round for Microbiome Research

Altis Biosystems, developer of RepliGut replicating the human intestinal epithelium for microbiome pharma and biotech research, closed a $3.1 million seed round led by VentureSouth with RTP Capital, Hatteras Ventures, Atlanta Technology Angels and Central Texas Angel Network participating. Funds will be used to develop and deploy additional intestinal models with pharma and biotech partners. [Full story]